2024
Since then, our business has had many names and focuses but in 2016, we came full circle and formed Sterling Pharma Solutions, an independent organisation with a focus on excellent customer service.
Today, we have over 50 years’ experience in contract research, development and manufacturing, six facilities and over 1,300 employees.
Together our facilities in the UK, US and EU offer first-class small molecule API services for the full product lifecycle from preclinical to commercial manufacture. Most recently, we have also added a highly experienced team in ADC discovery and development services, offering our customers an even wider portfolio of expertise.
